BioTime Acquisition Corporation (BAC) jointly has entered into a non-binding letter of intent (LOI) with Geron Corporation… Read more…
Cell Cure Neurosciences Ltd… Read more…
GERN acknowledged the public release by BTX of a letter to Geron’s stockholders regarding stem cell assets. Read more…
Regarding GERN’s stem cell assets … Read more…
Is there more to come …? Read more…
Net loss was $5.5M or $0.11 per share Read more…
Net loss was $5M or $0.10 per share Read more…
First demonstration of a scalable source of highly purified and identified progenitor cells Read more…
Acquisition will integrate GeneCards^® Read more…
An annual PanC-Dx^TM blood test could be the future alternative to the mammogram Read more…
Founder and Director of Research, Henry McCusker enters his tenth (10) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.
I started this blog to add commentary, update news flow and insightful opinions that are intelligent, fit to print and SEC compliant.